RITHOLTZ WEALTH MANAGEMENT

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1698218 NEW YORK, NY

Position in TEVA

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$694,201

+$137,313 QoQ

Shares Held

20,490

+10.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#362

of 671 holders

Holding Since

Sep 2022

10 quarters on record

Voting authority Sole 1% Shared 0% None 99%

Healthcare · as of Jun 30, 2026

RITHOLTZ WEALTH MANAGEMENT holds $18,229,387 across 17 Drug Manufacturers - Specialty & Generic names. TEVA ranks #8 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INDV	Indivior Pharmaceuticals, Inc.	121,304	$4,977,103
2	VTRS	Viatris Inc	200,979	$3,191,546
3	AMRX	Amneal Pharmaceuticals, Inc.	101,808	$1,762,296
4	IRWD	Ironwood Pharmaceuticals Inc	360,094	$1,515,995
5	ALKS	Alkermes plc.	25,487	$1,335,518
6	UTHR	UNITED THERAPEUTICS Corp	1,905	$1,032,186
7	BHC	Bausch Health Companies Inc.	181,540	$894,992
8	TEVA	Teva Pharmaceutical Industries Ltd This page	20,490	$694,201

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$694,201	20,490	+10.8%	Shares	Sole	2026-08-11
2026-03-31	$556,888	18,489	+69.4%	Shares	Sole	2026-04-20
2025-12-31	$340,657	10,915	+9.0%	Shares	Sole	2026-01-23
2025-09-30	$202,202	10,010	-4.7%	Shares	Sole	2025-10-28
2025-06-30	$176,114	10,508	-51.8%	Shares	Sole	2025-07-28
2025-03-31	$334,927	21,791	-37.7%	Shares	Sole	2025-04-17
2024-12-31	$770,386	34,954	-16.1%	Shares	Sole	2025-01-15
2024-09-30	$750,406	41,643	+269.5%	Shares	Sole	2024-10-10
2024-06-30	$183,121	11,269	+6.7%	Shares	Sole	2024-08-01
2022-09-30	$85,219	10,560	—	Shares	Sole	2022-10-19
No filing history on record for this holder in this stock.